Direct Funds

Italchimici is an Italian pharmaceutical company, leader in the sale of generic drugs and proprietary branded food supplements. Founded in the 60s by the Guastella family in Pomezia (near Rome), Italchimici carried on a co-marketing business with Janssen (a pharmaceutical company of Johnson & Johnson) in the 70s. In 1988 it was acquired by the multinational company Fisons Pic, a global leader mondiale in the respiratory and allergy treatments. In 1995, following the acquisition by Fison Pic, it joined Rhône-Poulenc (currently Sanofi-Aventis), and in 1996 it was taken over by its managers and private investors through a MBO. Italchimici sells products dedicated to the respiratory and gastrointestinal therapies, having established a leadership position in its markets in Italy, in particular in the pediatric and in the probiotics and nutraceuticals segments. The products are promoted directly to the doctors through its sales and pharmaceutical representatives network. The promotional activity, that has been carried out in the recent years, has contributed to place its brands in a leadership position. Italchimici possesses a prominent green angle considering that it develops almost a third of its turnover in nutraceuticals and dietary supplements with specific functional qualities. The fund sold to Recordati S.p.A. its stake in Italchimici S.p.A. on May 31, 2016.